Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HHT”

151 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 151 results

Not applicableWithdrawnNCT00733629
What this trial is testing

Study of Endothelial Cells in Patients With Hereditary Haemorrhagic Telangiectasia

Who this might be right for
Telangiectasia, Hereditary Hemorrhagic
Imperial College London
Not applicableUnknownNCT02458703
What this trial is testing

Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs With and Without Airflow Obstruction

Who this might be right for
Pulmonary Arteriovenous MalformationsHereditary Hemorrhagic TelangiectasiaAsthma+1 more
Imperial College London 60
Testing effectiveness (Phase 2)Ended earlyNCT02204371
What this trial is testing

Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia

Who this might be right for
Telangiectasia, Hereditary Hemorrhagic
GlaxoSmithKline 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07601425
What this trial is testing

Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)

Who this might be right for
Hereditary Hemorrhagic Telangiectasia (HHT)Osler Weber Rendu Disease
Atavistik Bio, Inc 100
Testing effectiveness (Phase 2)Study completedNCT03954782
What this trial is testing

Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease.

Who this might be right for
Telangiectasia, Hereditary HemorrhagicRendu Osler Disease
Hospices Civils de Lyon 61
Testing effectiveness (Phase 2)Study completedNCT04646356
What this trial is testing

Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)

Who this might be right for
Hereditary Hemorrhagic TelangiectasiaEpistaxis Nosebleed
Unity Health Toronto 10
Testing effectiveness (Phase 2)UnknownNCT03135054
What this trial is testing

Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD

Who this might be right for
AMLFLT3-ITD Mutation
The University of Hong Kong 40
Not applicableStudy completedNCT00230672
What this trial is testing

Investigation of Plasma Proteins in Patients With Hereditary Haemorrhagic Telangiectasia and PAVMs

Who this might be right for
Telangiectasia, Hereditary Hemorrhagic
Imperial College London 1
Not applicableStudy completedNCT02983253
What this trial is testing

Immunmodulation in Patients With HHT

Who this might be right for
Hereditary Haemorrhagic Telangiectasia (HHT)
University Hospital, Essen 124
Testing effectiveness (Phase 2)Ended earlyNCT00588146
What this trial is testing

Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia

Who this might be right for
AnemiaLiver DiseaseHypoxemia
Mayo Clinic 10
Testing effectiveness (Phase 2)Ended earlyNCT02078960
What this trial is testing

Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study)

Who this might be right for
Chronic Myeloid Leukemia
Teva Branded Pharmaceutical Products R&D, Inc. 10
Not applicableNot Yet RecruitingNCT07101575
What this trial is testing

Cardiac Evaluation in Hereditary Hemorrhagic Telangiectasia

Who this might be right for
Hereditary Hemorrhagic Telangiectasia
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 380
Testing effectiveness (Phase 2)Active Not RecruitingNCT04404881
What this trial is testing

Bevacizumab In Hereditary Hemorrhagic Telangiectasia

Who this might be right for
Hereditary Hemorrhagic Telangiectasia
Hanny Al-Samkari, MD 33
Post-approval studies (Phase 4)Study completedNCT02389959
What this trial is testing

Intranasal Bevacizumab for HHT-Related Epistaxis

Who this might be right for
HHTHereditary Hemorrhagic TelangiectasiaEpistaxis+2 more
Stanford University 40
Not applicableStudy completedNCT03586115
What this trial is testing

Minimal Hepatic Encephalopathy in Hereditary Hemorrhagic Telangiectasian

Who this might be right for
Hepatic EncephalopathyMinimal Brain Dysfunction
University of Bari 50
Testing effectiveness (Phase 2)Study completedNCT00003694
What this trial is testing

Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase

Who this might be right for
Chronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Phase Chronic Myelogenous Leukemia
National Cancer Institute (NCI) 60
Not applicableActive Not RecruitingNCT06266624
What this trial is testing

Tourniquet-Test in HHT

Who this might be right for
HHT
University Hospital, Essen 92
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07505160
What this trial is testing

Efficacy and Safety of Lisafotoclax Plus Decitabine and Homoharringtonine in Venetoclax/Azacitidine Pretreated AML Patients

Who this might be right for
Acute Myeloid Leukemia (AML)
Second Affiliated Hospital, School of Medicine, Zhejiang University 35
Large-scale testing (Phase 3)Looking for participantsNCT06810791
What this trial is testing

HVA vs IA/DA or VA in the Treatment of ND HR-AML

Who this might be right for
Newly Diagnosed Acute Myeloid Leukemia With High Risk
Nanfang Hospital, Southern Medical University 876
Not applicableStudy completedNCT02936349
What this trial is testing

Graded TTCE for Post-Embolization PAVM Monitoring

Who this might be right for
Hereditary Hemorrhagic Telangiectasia (HHT)
University of Pennsylvania 32
Load More Results